Variantyx is a Biotech company based in Framingham. It has raised $125M in total funding. Latest round: Growth.
Variantyx funding overview
Variantyx is a Biotech company based in Framingham. Variantyx has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in April 2024. The round record for Variantyx runs through 2024; nothing later has been disclosed. Investors on record include Peregrine Ventures, Pitango HealthTech, New Era Capital Partners, Bosch Ventures, 20/20 HealthCare Partners. 5 distinct backers are named across the disclosed rounds.
Variantyx at a glance
Total raised
$125M
Latest round
Growth
Latest round date
April 2024
Industry
Biotech
Headquarters
Framingham
Notable investors
Peregrine Ventures, Pitango HealthTech, New Era Capital Partners, Bosch Ventures, 20/20 HealthCare Partners
Frequently asked about Variantyx funding
How much has Variantyx raised?
Variantyx has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Variantyx?
Peregrine Ventures, Pitango HealthTech, New Era Capital Partners, Bosch Ventures, 20/20 HealthCare Partners are named among the investors backing Variantyx.
What was the latest Variantyx funding round?
The most recent disclosed round is a Growth, announced in April 2024.
Where is Variantyx based?
Variantyx is based in Framingham.
What sector does Variantyx operate in?
Variantyx is tracked under Biotech from Framingham, with $125M in disclosed funding.
When did Variantyx last raise?
The last disclosed Variantyx round closed in April 2024 at Growth.
Round data for Variantyx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Framingham and backer lists below.
